NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA. 1993;270:83–90.

Article  Google Scholar 

Quilter M, Hodges L, von Hurst P, Borman B, Coad J. Male sexual function in New Zealand: a population-based cross-sectional survey of the prevalence of erectile dysfunction in men aged 40–70 years. J Sex Med. 2017;14:928–36.

Article  PubMed  Google Scholar 

Çayan S, Kendirci M, Yaman Ö, Aşçı R, Orhan İ, Usta MF, et al. Prevalence of erectile dysfunction in men over 40 years of age in Turkey: results from the Turkish society of andrology male sexual health study group. Turk J Urol. 2017;43:122–9.

Article  PubMed  PubMed Central  Google Scholar 

Corona G, Lee DM, Forti G, O’Connor DB, Maggi M, O’Neill TW, et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med. 2010;7:1362–80.

Article  PubMed  Google Scholar 

Buvat J, Glasser D, Neves RCS, Duarte FG, Gingell C, Moreira ED, et al. Sexual problems and associated help-seeking behavior patterns: results of a population-based survey in France. Int J Urol. 2009;16:632–8.

Article  PubMed  Google Scholar 

Teles AG, Carreira M, Alarcão V, Sociol D, Aragüés JM, Lopes L, et al. Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3548 portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study. J Sex Med. 2008;5:1317–24.

Article  PubMed  Google Scholar 

Laumann EO, Glasser DB, Neves RCS, Moreira ED, GSSAB Investigators’ Group. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 2009;21:171–8.

Article  CAS  PubMed  Google Scholar 

Capogrosso P, Ventimiglia E, Boeri L, Pozzi E, Chierigo F, Schifano N, et al. Should we tailor the clinical management of erectile dysfunction according to different ages? J Sex Med. 2019;16:999–1004.

Article  PubMed  Google Scholar 

Capogrosso P, Ventimiglia E, Boeri L, Cazzaniga W, Chierigo F, Pederzoli F, et al. Age at first presentation for erectile dysfunction: analysis of changes over a 12-yr period. Eur Urol Focus. 2019;5:899–905.

Article  PubMed  Google Scholar 

Elterman DS, Bhattacharyya SK, Mafilios M, Woodward E, Nitschelm K, Burnett AL. The quality of life and economic burden of erectile dysfunction. Res Rep. Urol. 2021;13:79–86.

PubMed  PubMed Central  Google Scholar 

Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol. 2021;80:333–57.

Article  PubMed  Google Scholar 

Ventimiglia E, Cazzaniga W, Pederzoli F, Frego N, Chierigo F, Capogrosso P, et al. The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study. Andrology. 2018;6:559–63.

Article  CAS  PubMed  Google Scholar 

Boeri L, Capogrosso P, Pederzoli F, Ventimiglia E, Frego N, Chierigo F, et al. Unrecognized prediabetes is highly prevalent in men with erectile dysfunction-results from a cross-sectional study. J Sex Med. 2018;15:1117–24.

Article  PubMed  Google Scholar 

Althof SE, O’leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S, et al. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: results from an international, multi-center, double-blind, placebo-controlled trial. J Sex Med. 2006;3:521–9.

Article  CAS  PubMed  Google Scholar 

Shabsigh R, Kim ED, Rosen RC, Shinghal R, Natanegara F, Muram D, et al. Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline. Int J Impot Res. 2008;20:554–60. https://doi.org/10.1038/ijir.2008.38.

Article  CAS  PubMed  Google Scholar 

Porst H, Rosen R, Padma-Nathan H, Goldstein I, Giuliano F, Ulbrich E, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13:192–9. https://doi.org/10.1038/sj.ijir.3900713.

Article  CAS  PubMed  Google Scholar 

Hellstrom WJG, Freier MT, Serefoglu EC, Lewis RW, DiDonato K, Peterson CA. A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction. BJU Int. 2013;111:137–47.

Article  CAS  PubMed  Google Scholar 

Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. N Engl J Med. 1996;334:873–7.

Article  CAS  PubMed  Google Scholar 

Dutta TC, Eid JF. Vacuum constriction devices for erectile dysfunction: a long-term, prospective study of patients with mild, moderate, and severe dysfunction. Urology. 1999;54:891–3.

Article  CAS  PubMed  Google Scholar 

Chierigo F, Capogrosso P, Dehò F, Pozzi E, Schifano N, Belladelli F, et al. Long-term follow-up after penile prosthesis implantation-survival and quality of life outcomes. J Sex Med. 2019;16:1827–33.

Article  PubMed  Google Scholar 

Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol. 2012;187:1769–75.

Article  PubMed  Google Scholar 

Haahr MK, Jensen CH, Toyserkani NM, Andersen DC, Damkier P, Sørensen JA, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine. 2016;5:204–10.

Article  PubMed  PubMed Central  Google Scholar 

Ding X-G, Li S-W, Zheng X-M, Hu L-Q, Hu W-L, Luo Y. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl. 2009;11:215–21.

Article  PubMed  PubMed Central  Google Scholar 

Wu C-C, Wu Y-N, Ho H-O, Chen K-C, Sheu M-T, Chiang H-S. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J Sex Med. 2012;9:2838–48.

Article  PubMed  Google Scholar 

Anastasiadis E, Ahmed R, Khoja AK, Yap T. Erectile dysfunction: is platelet-rich plasma the new frontier for treatment in patients with erectile dysfunction? A review of the existing evidence. Front Reprod health. 2022;4:944765.

Article  PubMed  PubMed Central  Google Scholar 

Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10:225–8.

Article  CAS  PubMed  Google Scholar 

Daif ET. Effect of autologous platelet-rich plasma on bone regeneration in mandibular fractures. Dent Traumatol. 2013;29:399–403.

Article  CAS  PubMed  Google Scholar 

Taschieri S, Lolato A, Ofer M, Testori T, Francetti L, Del Fabbro M. Immediate post-extraction implants with or without pure platelet-rich plasma: a 5-year follow-up study. Oral Maxillofac Surg. 2017;21:147–57.

Article  PubMed  Google Scholar 

Alkandari MH, Touma N, Carrier S. Platelet-rich plasma injections for erectile dysfunction and peyronie’s disease: a systematic review of evidence. Sex Med Rev. 2022;10:341–52.

Article  PubMed  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–41.

Article  PubMed  Google Scholar 

Hartmann KE, Matchar DB, Chang S. Chapter 6: assessing applicability of medical test studies in systematic reviews. J Gen Intern Med. 2012;27:S39–46.

Article  PubMed  Google Scholar 

Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology. 1999;54:346–51.

Article  CAS  PubMed  Google Scholar 

Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–26. https://doi.org/10.1038/sj.ijir.3900472.

Article  CAS  PubMed  Google Scholar 

Howick J. The Oxford 2011 levels of evidence. Oxford: Oxford Centre for Evidence-Based Medicine; 2011. http://www.cebm.net/index.aspx?o=5653.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

Article  PubMed  Google Scholar 

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.

Article  PubMed  PubMed Central  Google Scholar 

Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805.

Article  PubMed  Google Scholar 

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

Article